Milena Perez Mak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Breakthrough drug halts lung cancer and brain metastases

D'Or Institute for Research and Education (IDOR) played an important role in the phase III LIBRETTO-431 multicenter study, which evaluated the efficacy and safety of selpercatinib compared to control treatment, which consisted of platinum-based chemotherapy associated or not with pembrolizumab (immune checkpoint inhibitor) in non-small cell lung cancer (NSCLC).

Paulo state cancer institute icespDor institute for researchPaulo state cancer instituteNew england journalMilena perez makPaulo state cancerLung cancerNon small cell lung cancerSmall cell lung cancerBrain metastases

Evaluating selpercatinib for the treatment of non-small cell lung cancer

Evaluating selpercatinib for the treatment of non-small cell lung cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Caicun zhouDor institute for researchPaulo state cancer institute icespNew england journalMilena perez makD or institutePaulo state cancer instituteFirst line selpercatinib

IDOR Evaluates Selpercatinib in Non-Small Cell Lung Cancer Study

IDOR Evaluates Selpercatinib in Non-Small Cell Lung Cancer Study
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Dor institute for researchPaulo state cancer institute icespD or instituteNew england journalMilena perez makPaulo state cancer institute